Endocrinology, Vol 129, 1727-1734, Copyright © 1991 by Endocrine Society

ARTICLES

Characterization of immunoreactive insulin-like growth factor-I from leukocytes and its regulation by growth hormone

JB Baxter, JE Blalock and DA Weigent
University of Alabama, Department of Physiology and Biophysics, Birmingham 35294-0005.

In the present study, we investigated the production of insulin-like growth factor I (IGF-I) by leukocytes and its production after treatment with GH. Immunoreactive (ir) IGF-I was observed in leukocytes by direct immunofluorescence with fluorescein isothiocynate-conjugated antibodies to IGF-I. Studies using immunoaffinity purification, HPLC and a fibroblast proliferation bioassay suggests that the de novo synthesized leukocyte-derived irIGF-I is similar in mol wt, antigenicity, and bioactivity to serum IGF-I. We also evaluated the effect of GH on the production of leukocyte-derived irIGF-I. Spleen cells cultured for 24 h in the presence of exogenous GH caused a 2-fold elevation of irIGF-I as demonstrated by RIA and immunofluorescence. In order to determine if leukocyte-derived irGH can stimulate the production of irIGF-I, we cultured spleen cells for 24 h in the presence of antibodies specific for GH. The data showed a decrease in the number of cells positive for irIGF-I, suggesting that leukocyte- derived irGH may stimulate the synthesis of irIGF-I by leukocytes. We also demonstrated that exogenous IGF-I can decrease the levels of leukocyte GH-related RNA and ir protein. Taken together, our data demonstrate the synthesis and secretion of bioactive irIGF-I from leukocytes and suggest a regulatory circuit for leukocyte-derived irGH and irIGF-I within the immune system.

This article has been cited by other articles:

				A. Toyofuku, T. Hara, T. Taguchi, Y. Katsura, K. Ohama, and Y. Kudo Cyclic and characteristic expression of phosphorylated Akt in human endometrium and decidual cells in vivo and in vitro Hum. Reprod., May 1, 2006; 21(5): 1122 - 1128. [Abstract] [Full Text] [PDF]

				L. A. Welniak, R. Sun, and W. J. Murphy The role of growth hormone in T-cell development and reconstitution J. Leukoc. Biol., March 1, 2002; 71(3): 381 - 387. [Abstract] [Full Text] [PDF]

				M. G. Brocardo, R. Schillaci, A. Galeano, M. Radrizzani, V. White, A. G. Guerrico, T. A. Santa-Coloma, and A. Roldan Early effects of insulin-like growth factor-1 in activated human T lymphocytes J. Leukoc. Biol., August 1, 2001; 70(2): 297 - 305. [Abstract] [Full Text] [PDF]

				W. Tu, P.-T. Cheung, and Y.-L. Lau Insulin-Like Growth Factor 1 Promotes Cord Blood T Cell Maturation and Inhibits Its Spontaneous and Phytohemagglutinin-Induced Apoptosis Through Different Mechanisms J. Immunol., August 1, 2000; 165(3): 1331 - 1336. [Abstract] [Full Text] [PDF]

				C. R. Vines and D. A. Weigent Identification of SP3 as a Negative Regulatory Transcription Factor in the Monocyte Expression of Growth Hormone Endocrinology, March 1, 2000; 141(3): 938 - 946. [Abstract] [Full Text] [PDF]

				S. B. Solerte, M. Fioravanti, G. Vignati, A. Giustina, L. Cravello, and E. Ferrari Dehydroepiandrosterone Sulfate Enhances Natural Killer Cell Cytotoxicity in Humans Via Locally Generated Immunoreactive Insulin-Like Growth Factor I J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3260 - 3267. [Abstract] [Full Text]

				O. Khorram, M. Yeung, L. Vu, and S. S. C. Yen Effects of [Norleucine27]Growth Hormone-Releasing Hormone (GHRH) (1-29)-NH2 Administration on the Immune System of Aging Men and Women J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3590 - 3596. [Abstract] [Full Text] [PDF]

				L Powell-Braxton, P Hollingshead, C Warburton, M Dowd, S Pitts-Meek, D Dalton, N Gillett, and T A Stewart IGF-I is required for normal embryonic growth in mice. Genes & Dev., December 1, 1993; 7(12b): 2609 - 2617. [Abstract] [PDF]